A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.

The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...

To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...

FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris ...

The Syndeo pump could be reintroduced after Baxter fixes its design problems. CDRH has historically been suspicious about the reliability of infusion pumps. Incidents with two pump makers in 2006 have ...

A vulnerability found in software used to monitor some of BD’s infusion pumps could potentially give hackers access to personal data stored in the system. BD posted a cybersecurity bulletin about the ...

ST. LOUIS (First Alert 4) - A local healthcare worker has a warning for patients at BJC facilities. If you need an IV for medicine or blood, one whistleblower tells First Alert 4 Investigates the ...